A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF CC-95266 IN SUBJECTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
NOT ENROLLING
Trial ID:
NCT04674813 Protocol # :
21-019
Phase
I
Disease Sites
Multiple Myeloma
Principal Investigator
Nadeem, Omar
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-019
21-019